Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024723 · ClinicalTrials.gov registry record
Nasal Continuous Positive Airway Pressure and Airway Patency in Obese Patient
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 32
- Enrollment target
NCT03024723: Completed study, sponsored by Massachusetts General Hospital.
NCT03024723 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03024723 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The mechanism of Upper airway obstruction (UAO) during anesthesia shares many similarities with the upper airway obstruction observed during obstructive sleep apnea (OSA). Nasal continuous positive airway pressure (nCPAP) via nasal mask (NM) can maintain the airway patent with near 100% success in patients with OSA. Obesity is a major risk factors for obstructive sleep apnea and obese patients have a higher prevalence of UAO during anesthesia. The investigators hypotheses that nCPAP should eliminate airway obstruction in obese patients under anesthesia. The investigators propose to test this hypothesis and determine the efficacy of nCPAP on maintaining airway patency in obese patients who require general anesthesia compared with CPAP administering face mask.
Interventions
- DEVICE nasal mask CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03024723
The ClinicalTrials.gov registry entry for NCT03024723 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nasal mask CPAP is the first listed.
NCT03024723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03024723 about?
NCT03024723 is a clinical study titled "Nasal Continuous Positive Airway Pressure and Airway Patency in Obese Patient". The mechanism of Upper airway obstruction (UAO) during anesthesia shares many similarities with the upper airway obstruction observed during obstructive sleep apnea (OSA). Nasal continuous positive airway pressure (nCPAP) via nasal mask (NM) can maintain the airway patent with near 100% success in p...
What is the current status of trial NCT03024723?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT03024723?
The interventions under investigation include: nasal mask CPAP (DEVICE).
Who is sponsoring clinical trial NCT03024723?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.